Leanne Harling, Doug Mathisen, and Erino Rendina share and debate their approaches to staging, adjuvant therapy, persistent disease, and surgical removal of the primary tumor.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
March 22, 2020
A Fasco in the Making? As the Coronavirus Pandemic Takes Hold, We Are Making Decisions Without Reliable Data
March 20, 2020
Interesting input from a Stanford expert on the hottest topic on the planet at the moment.
March 18, 2020
The authors describe a thoughtful process for resource utilization in the setting of competing needs that optimizes survival for a popultion. Examples of existing guidelines are provided.
March 18, 2020
The authors examined the SEER database to assess racial disparities in use of PET for lung cancer staging 2007-2015 and subsequent one-year survival. Blacks (OR 0.54) and Hispanics (OR 0.72) were less likely to undergo PET compared to non-Hispanic whites. Use of PET was associated with improved survival (HR 0.61).
Surgery Performed at Night by Continuously Working Surgeons Contributes to a Higher Incidence of Intraoperative Complications in Video-Assisted Thoracoscopic Pulmonary Resection: A Large Monocentric Retrospective Study
March 13, 2020
This article analyzes the outcome of video-assisted thoracoscopic lung resections performed at night compared to daytime operations. Nighttime operations carried a higher risk of intraoperative complications. The authors conclude surgeons should avoid nighttime operations whenever possible.
February 17, 2020
This video demonstrates a trainee-led open resection of four pulmonary nodules using the LEONARDO® Dual Wave 200W laser system.
February 13, 2020
Richard Booton of the Manchester University NHS Foundation in the United Kingdom presents a discussion on lung health checks and lung cancer screening.
February 8, 2020
The newest version of the ASCO guidelines for lung cancer surveillance after curative lung cancer therapy is presented. The overall quality of supportive evidence is low, and the strength of recommendations is moderate. CT is recommended as the optimal imaging modality.
February 3, 2020
This interesting study compared bronchial epithelial mutation burden, the primary source of new lung cancers, among nonsmokers, former smokers, and current smokers. Smoking typically adds 1,000 to 10,000 mutations per cell. Smoking cessation in this study was associated with replenishment of the abnormal epithelium with cells that are typical of no
February 1, 2020
Individuals at high risk for lung cancer were randomized to low dose CT screening (years 0, 1, 3, and 5.5) or observation. At 10 years the cumulative rate ratio for lung cancer death was 0.76 in the screened population of men (p=0.01) and 0.67 in the screened population of women, demonstrating a strong benefit for screening.